Veralto growth slows to 1.9% as PQI sales turn negative; $426M In-Situ deal closes

Filed April 29, 2026 · Period ending April 3, 2026 · Compared to 10-Q Apr 30, 2025 · ~1 min read

Key Changes

• high

  Core sales growth decelerated sharply to 1.9% in Q1 2026 from 7.8% in Q1 2025, driven by Product Quality & Innovation segment turning negative (-1.0% vs. +8.3% prior year) amid global macroeconomic headwinds.

  MD&A: Core Sales Growth verify on EDGAR →
• high

  Acquired In-Situ for $426M cash (January 2026) and GlobalVision for ~CAD $270M (April 2026), adding water-quality monitoring and AI-augmented packaging compliance capabilities; transaction costs and inventory adjustments compressed operating margin 40 bps year-over-year to 23.8%.

  MD&A: Acquisitions & Operating Margin verify on EDGAR →
• high

  New tariff and trade-policy risk disclosure warns U.S. import restrictions and foreign countermeasures could adversely affect business; management implementing countermeasures as trade-policy uncertainty persists.

  MD&A: Tariff Risk verify on EDGAR →